Cargando…

Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach

The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Hanno, Malik, Assaf, Bicker, Anne, Poetzsch, Gesa, Avivi, Aaron, Shams, Imad, Hankeln, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662568/
https://www.ncbi.nlm.nih.gov/pubmed/29084988
http://dx.doi.org/10.1038/s41598-017-13905-z
_version_ 1783274654806310912
author Schmidt, Hanno
Malik, Assaf
Bicker, Anne
Poetzsch, Gesa
Avivi, Aaron
Shams, Imad
Hankeln, Thomas
author_facet Schmidt, Hanno
Malik, Assaf
Bicker, Anne
Poetzsch, Gesa
Avivi, Aaron
Shams, Imad
Hankeln, Thomas
author_sort Schmidt, Hanno
collection PubMed
description The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver tissue. Hypoxic Spalax broadly downregulates genes from major liver function pathways. This energy-saving response is likely a crucial adaptation to low oxygen levels. In contrast, the hypoxia-sensitive rat shows massive upregulation of energy metabolism genes. Candidate genes with plausible connections to the mole rat’s phenotype, such as important key genes related to hypoxia-tolerance, DNA damage repair, tumourigenesis and ageing, are substantially higher expressed in Spalax than in rat. Comparative liver transcriptomics highlights the importance of molecular adaptations at the gene regulatory level in Spalax and pinpoints a variety of starting points for subsequent functional studies.
format Online
Article
Text
id pubmed-5662568
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-56625682017-11-08 Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach Schmidt, Hanno Malik, Assaf Bicker, Anne Poetzsch, Gesa Avivi, Aaron Shams, Imad Hankeln, Thomas Sci Rep Article The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver tissue. Hypoxic Spalax broadly downregulates genes from major liver function pathways. This energy-saving response is likely a crucial adaptation to low oxygen levels. In contrast, the hypoxia-sensitive rat shows massive upregulation of energy metabolism genes. Candidate genes with plausible connections to the mole rat’s phenotype, such as important key genes related to hypoxia-tolerance, DNA damage repair, tumourigenesis and ageing, are substantially higher expressed in Spalax than in rat. Comparative liver transcriptomics highlights the importance of molecular adaptations at the gene regulatory level in Spalax and pinpoints a variety of starting points for subsequent functional studies. Nature Publishing Group UK 2017-10-30 /pmc/articles/PMC5662568/ /pubmed/29084988 http://dx.doi.org/10.1038/s41598-017-13905-z Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Schmidt, Hanno
Malik, Assaf
Bicker, Anne
Poetzsch, Gesa
Avivi, Aaron
Shams, Imad
Hankeln, Thomas
Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title_full Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title_fullStr Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title_full_unstemmed Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title_short Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
title_sort hypoxia tolerance, longevity and cancer-resistance in the mole rat spalax – a liver transcriptomics approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662568/
https://www.ncbi.nlm.nih.gov/pubmed/29084988
http://dx.doi.org/10.1038/s41598-017-13905-z
work_keys_str_mv AT schmidthanno hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT malikassaf hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT bickeranne hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT poetzschgesa hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT aviviaaron hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT shamsimad hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach
AT hankelnthomas hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach